Comparable stake leader
LAW CUSTODIAL INC.
SEC ownership of Dare Bioscience, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001401914.
Disclosed value leader
VANGUARD CAPITAL MANAGEMENT LLC
Comparable rows
1/36
Latest evidence
30 Jun 2026
- Public ticker
- DARE on Nasdaq
- Parsed ownership sources
-
13D/G, 13F, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
LAW CUSTODIAL INC.
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
1 of 36
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
LAW CUSTODIAL INC.
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001401914
- Issuer location
- San Diego, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Dare Bioscience, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
LAW CUSTODIAL INC.
Disclosed value leader
VANGUARD CAPITAL MANAGEME...
Comparable rows
1/36
Latest evidence
30 Jun 2026
13D/G
13F
3/4/5
Lead comparable stake: 7.8%
35 rows are not safely comparable across share classes.
13D/G row: LAW CUSTODIAL INC.
Showing 1-8 of 36 holder rows.
Quick read
LAW CUSTODIAL INC. leads the comparable SEC ownership view at 7.8%.
1 of 36 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens LAW CUSTODIAL INC.'s linked filing trail.
Comparable ownership
Top 1
LAW CUSTODIAL INC.
7.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 36 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| LAW CUSTODIAL INC. |
13D/G
|
7.8%
|
—
|
$0 | 22 Dec 2025 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
—
class O/S missing
|
$841,395
462,305 shares
|
— | 31 Mar 2026 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$323,703
177,839 shares
|
— | 31 Mar 2026 |
| US BANCORP \DE\ |
13F
Company
|
—
class O/S missing
|
$166,293
91,370 shares
|
— | 31 Mar 2026 |
| VANGUARD FIDUCIARY TRUST CO |
13F
Company
|
—
class O/S missing
|
$120,007
65,938 shares
|
— | 31 Mar 2026 |
| Robin Joan Steele |
3/4/5
Director
|
—
mixed-class rows
|
$85,640
57,055 shares
mixed-class rows
|
— | 30 Jun 2026 |
| UBS Group AG |
13F
Company
|
—
class O/S missing
|
$78,921
43,363 shares
|
— | 31 Mar 2026 |
| William H. Rastetter |
3/4/5
Director
|
—
mixed-class rows
|
$72,292
49,721 shares
mixed-class rows
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 13 Jul 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-11 of 11 reporting-owner rows connected to Dare Bioscience, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
11
Largest Forms 3/4/5 holder
Robin Joan Steele
Net 12M change
$0
Latest report
30 Jun 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Robin Joan Steele | Director | $85,640 | Median | 30 Jun 2026 | ||
| William H. Rastetter | Director | $72,292 | Median | 30 Jun 2026 | ||
| Gregory W. Matz | Director | $56,141 | Median | 30 Jun 2026 | ||
| Jessica D. Grossman | Director | $47,440 | Median | 30 Jun 2026 | ||
| Susan L. Kelley | Director | $43,126 | Median | 30 Jun 2026 | ||
| John A. Fair | Chief Commercial Officer | Mixed | 12 Mar 2024 | |||
| Nnenna Ononye Onyia | Director | Mixed | 21 Jun 2023 | |||
| MarDee Haring-Layton | Chief Accounting Officer | Mixed | 30 Jan 2026 | |||
| Cheryl R. Blanchard | Director | Mixed | 21 Jun 2023 | |||
| Sabrina Martucci Johnson | Chef Executive Officer, Director | Mixed | 18 Feb 2026 | |||
| Lisa Walters-Hoffert | Chief Financial Officer | Mixed | 24 Jan 2023 |
Recent insider transactions for Dare Bioscience, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Jessica D. Grossman | DARE | Common stock | Award | 26,066 | 26,066 | 30 Jun 2026 | Direct | |||
| Susan L. Kelley | DARE | Common stock | Award | 23,696 | 23,696 | 30 Jun 2026 | Direct | |||
| Gregory W. Matz | DARE | Common stock | Award | 73345.2% | 30,805 | 30,847 | 30 Jun 2026 | Direct | ||
| William H. Rastetter | DARE | Common stock | Award | 4524.1% | 38,862 | 39,721 | 30 Jun 2026 | Direct | ||
| Robin Joan Steele | DARE | Common stock | Award | 129.4% | 26,540 | 47,055 | 30 Jun 2026 | Direct | ||
| William H. Rastetter | DARE | Stock Option (right to buy) | Award | 10,000 | 10,000 | 11 Jun 2026 | Direct | |||
| Susan L. Kelley | DARE | Stock Option (right to buy) | Award | 10,000 | 10,000 | 11 Jun 2026 | Direct | |||
| Robin Joan Steele | DARE | Stock Option (right to buy) | Award | 10,000 | 10,000 | 11 Jun 2026 | Direct | |||
| Gregory W. Matz | DARE | Stock Option (right to buy) | Award | 10,000 | 10,000 | 11 Jun 2026 | Direct | |||
| Jessica D. Grossman | DARE | Stock Option (right to buy) | Award | 10,000 | 10,000 | 11 Jun 2026 | Direct | |||
| Sabrina Martucci Johnson | DARE | Common Stock Warrant (right to buy) | Award | 21,600 | 21,600 | 18 Feb 2026 | Direct | |||
| Sabrina Martucci Johnson | DARE | Series A Convertible Preferred Stock | Award | 10,800 | 10,800 | 18 Feb 2026 | Direct | |||
| MarDee Haring-Layton | DARE | Employee Stock Option (right to buy) | Award | 49,000 | 49,000 | 30 Jan 2026 | Direct | |||
| Sabrina Martucci Johnson | DARE | Employee Stock Option (right to buy) | Award | 172,000 | 172,000 | 30 Jan 2026 | Direct | |||
| MarDee Haring-Layton | DARE | Employee Stock Option (right to buy) | Award | 57,000 | 57,000 | 04 Sep 2025 | Direct |
* marks a reported price that did not pass the local price check.